Resources from the same session
Introduction and scientific background
Presenter: Marianne Pavel
Session: Personalized oncology in thyroid cancers: Moving from multi-targeted agents to tumor agnostic indications?
Resources:
Slides
Webcast
Current management of advanced thyroid cancer in the era of targeted agents
Presenter: Dagmar Führer
Session: Personalized oncology in thyroid cancers: Moving from multi-targeted agents to tumor agnostic indications?
Resources:
Slides
Webcast
Tumor agnostics in thyroid cancer: RET
Presenter: Jaume Capdevila Castillon
Session: Personalized oncology in thyroid cancers: Moving from multi-targeted agents to tumor agnostic indications?
Resources:
Slides
Webcast
Tumor agnostics in thyroid cancer: NTRK, mTOR and immunotherapy
Presenter: Laura Locati
Session: Personalized oncology in thyroid cancers: Moving from multi-targeted agents to tumor agnostic indications?
Resources:
Slides
Webcast
Tumor agnostics in thyroid cancer: BRAF
Presenter: Maria Cabanillas
Session: Personalized oncology in thyroid cancers: Moving from multi-targeted agents to tumor agnostic indications?
Resources:
Slides
Webcast
Conclusions and perspectives
Presenter: Jaume Capdevila Castillon
Session: Personalized oncology in thyroid cancers: Moving from multi-targeted agents to tumor agnostic indications?
Resources:
Slides
Webcast